Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12782800rdf:typepubmed:Citationlld:pubmed
pubmed-article:12782800lifeskim:mentionsumls-concept:C0034802lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C0007137lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C0460004lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C1422009lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C1514762lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:12782800lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:12782800pubmed:issue6lld:pubmed
pubmed-article:12782800pubmed:dateCreated2003-6-3lld:pubmed
pubmed-article:12782800pubmed:abstractTextBoth the epidermal growth factor receptor (EGFR) and the p53 homologue p63 are overexpressed in a significant number of cases of head and neck squamous cell carcinoma (HNSCC). Epidermal growth factor receptor and p63 both possess oncogenic properties, including the potential to increase cell proliferation and antagonize apoptosis. ZD1839 ("Iressa") is an adenosine triphosphate-competitive inhibitor specific to the EGFR tyrosine kinase currently under evaluation as a chemotherapeutic agent in HNSCC. The objective was to investigate whether p63 expression is decreased after treatment of HNSCC cells with ZD1839. Downregulation of p63 by ZD1839 would identify a potential molecular relationship between EGFR signaling and p63 and could provide insight into the mechanism of action of ZD1839.lld:pubmed
pubmed-article:12782800pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:languageenglld:pubmed
pubmed-article:12782800pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:citationSubsetIMlld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12782800pubmed:statusMEDLINElld:pubmed
pubmed-article:12782800pubmed:monthJunlld:pubmed
pubmed-article:12782800pubmed:issn0023-852Xlld:pubmed
pubmed-article:12782800pubmed:authorpubmed-author:PietenpolJenn...lld:pubmed
pubmed-article:12782800pubmed:authorpubmed-author:ArteagaCarlos...lld:pubmed
pubmed-article:12782800pubmed:authorpubmed-author:SniezekJoseph...lld:pubmed
pubmed-article:12782800pubmed:authorpubmed-author:MathenyKeith...lld:pubmed
pubmed-article:12782800pubmed:authorpubmed-author:BarbieriChris...lld:pubmed
pubmed-article:12782800pubmed:issnTypePrintlld:pubmed
pubmed-article:12782800pubmed:volume113lld:pubmed
pubmed-article:12782800pubmed:ownerNLMlld:pubmed
pubmed-article:12782800pubmed:authorsCompleteYlld:pubmed
pubmed-article:12782800pubmed:pagination936-9lld:pubmed
pubmed-article:12782800pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:meshHeadingpubmed-meshheading:12782800...lld:pubmed
pubmed-article:12782800pubmed:year2003lld:pubmed
pubmed-article:12782800pubmed:articleTitleInhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells.lld:pubmed
pubmed-article:12782800pubmed:affiliationVanderbilt Bill Wilkerson Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.lld:pubmed
pubmed-article:12782800pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12782800pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:8626entrezgene:pubmedpubmed-article:12782800lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12782800lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12782800lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12782800lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12782800lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12782800lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12782800lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12782800lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12782800lld:pubmed